Acebutolol
The risk or severity of adverse effects can be increased when Acebutolol is combined with Pilocarpine.
Acetyl Sulfisoxazole
The metabolism of Pilocarpine can be decreased when combined with Acetyl sulfisoxazole.
Alprenolol
The risk or severity of adverse effects can be increased when Alprenolol is combined with Pilocarpine.
Advertisement
Ambenonium
The risk or severity of adverse effects can be increased when Ambenonium is combined with Pilocarpine.
Amiodarone
The metabolism of Pilocarpine can be decreased when combined with Amiodarone.
Apalutamide
The serum concentration of Pilocarpine can be decreased when it is combined with Apalutamide.
Advertisement
Aprepitant
The serum concentration of Pilocarpine can be increased when it is combined with Aprepitant.
Artesunate
The serum concentration of the active metabolites of Artesunate can be reduced when Artesunate is used in combination with Pilocarpine resulting in a loss in efficacy.
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Pilocarpine.
Advertisement
Asunaprevir
The serum concentration of Asunaprevir can be increased when it is combined with Pilocarpine.
Atazanavir
The metabolism of Pilocarpine can be decreased when combined with Atazanavir.
Atenolol
The risk or severity of adverse effects can be increased when Atenolol is combined with Pilocarpine.
Atomoxetine
The metabolism of Pilocarpine can be decreased when combined with Atomoxetine.
Atorvastatin
The risk or severity of adverse effects can be increased when Pilocarpine is combined with Atorvastatin.
Betaxolol
The risk or severity of adverse effects can be increased when Betaxolol is combined with Pilocarpine.
Bisoprolol
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Pilocarpine.
Boceprevir
The metabolism of Pilocarpine can be decreased when combined with Boceprevir.
Bopindolol
The risk or severity of adverse effects can be increased when Bopindolol is combined with Pilocarpine.
Bortezomib
The metabolism of Pilocarpine can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Pilocarpine can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Pilocarpine can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Pilocarpine.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Pilocarpine.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Pilocarpine.
Bupranolol
The risk or severity of adverse effects can be increased when Bupranolol is combined with Pilocarpine.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Pilocarpine.
Carbamazepine
The metabolism of Pilocarpine can be increased when combined with Carbamazepine.
Carteolol
The risk or severity of adverse effects can be increased when Carteolol is combined with Pilocarpine.
Carvedilol
The risk or severity of adverse effects can be increased when Carvedilol is combined with Pilocarpine.
Celiprolol
The risk or severity of adverse effects can be increased when Celiprolol is combined with Pilocarpine.
Ceritinib
The serum concentration of Pilocarpine can be increased when it is combined with Ceritinib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Pilocarpine.
Clarithromycin
The metabolism of Pilocarpine can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Pilocarpine can be decreased when combined with Clemastine.
Clotrimazole
The metabolism of Pilocarpine can be decreased when combined with Clotrimazole.
Cobicistat
The metabolism of Pilocarpine can be decreased when combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Pilocarpine.
Crizotinib
The metabolism of Pilocarpine can be decreased when combined with Crizotinib.
Curcumin
The metabolism of Pilocarpine can be decreased when combined with Curcumin.
Cyclosporine
The metabolism of Pilocarpine can be decreased when combined with Cyclosporine.
Cyproterone Acetate
The serum concentration of Pilocarpine can be decreased when it is combined with Cyproterone acetate.
Dabrafenib
The serum concentration of Pilocarpine can be decreased when it is combined with Dabrafenib.
Darunavir
The metabolism of Pilocarpine can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Pilocarpine can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Pilocarpine can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Pilocarpine can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Pilocarpine can be decreased when combined with Delavirdine.
Demecarium
The risk or severity of adverse effects can be increased when Demecarium is combined with Pilocarpine.
Desipramine
The risk or severity of adverse effects can be increased when Desipramine is combined with Pilocarpine.
Dihydroergocornine
The risk or severity of adverse effects can be increased when Dihydroergocornine is combined with Pilocarpine.
Dihydroergocristine
The risk or severity of adverse effects can be increased when Dihydroergocristine is combined with Pilocarpine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Pilocarpine.
Diltiazem
The metabolism of Pilocarpine can be decreased when combined with Diltiazem.
Dipivefrin
The risk or severity of adverse effects can be increased when Dipivefrin is combined with Pilocarpine.
Distigmine
The risk or severity of adverse effects can be increased when Distigmine is combined with Pilocarpine.
Donepezil
The risk or severity of adverse effects can be increased when Donepezil is combined with Pilocarpine.
Doxycycline
The metabolism of Pilocarpine can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Pilocarpine can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Pilocarpine can be decreased when combined with Dronedarone.
Echothiophate
The risk or severity of adverse effects can be increased when Echothiophate is combined with Pilocarpine.
Edrophonium
The risk or severity of adverse effects can be increased when Edrophonium is combined with Pilocarpine.
Enzalutamide
The serum concentration of Pilocarpine can be decreased when it is combined with Enzalutamide.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Pilocarpine.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Pilocarpine.
Erythromycin
The metabolism of Pilocarpine can be decreased when combined with Erythromycin.
Esmolol
The risk or severity of adverse effects can be increased when Esmolol is combined with Pilocarpine.
Fluconazole
The metabolism of Pilocarpine can be decreased when combined with Fluconazole.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Pilocarpine.
Fluvoxamine
The metabolism of Pilocarpine can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Pilocarpine can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Pilocarpine can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Pilocarpine can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Pilocarpine can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Pilocarpine can be increased when it is combined with Fusidic Acid.
Galantamine
The risk or severity of adverse effects can be increased when Galantamine is combined with Pilocarpine.
Gallamine Triethiodide
The risk or severity of adverse effects can be increased when Gallamine Triethiodide is combined with Pilocarpine.
Ginkgo biloba extract
The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Pilocarpine.
Hypoxis hemerocallidea root extract
The serum concentration of Pilocarpine can be decreased when it is combined with St. John's Wort.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Pilocarpine.
Idelalisib
The metabolism of Pilocarpine can be decreased when combined with Idelalisib.
Imatinib
The metabolism of Pilocarpine can be decreased when combined with Imatinib.
Indinavir
The metabolism of Pilocarpine can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Pilocarpine can be decreased when combined with Indinavir.
Isavuconazole
The serum concentration of Pilocarpine can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Pilocarpine can be decreased when combined with Isavuconazonium.
Isoflurophate
The risk or severity of adverse effects can be increased when Isoflurophate is combined with Pilocarpine.
Isoniazid
The metabolism of Pilocarpine can be decreased when combined with Isoniazid.
Isradipine
The metabolism of Pilocarpine can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Pilocarpine can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Pilocarpine can be increased when it is combined with Ivacaftor.
Ketoconazole
The metabolism of Pilocarpine can be decreased when combined with Ketoconazole.
Labetalol
The risk or severity of adverse effects can be increased when Labetalol is combined with Pilocarpine.
Levobetaxolol
The risk or severity of adverse effects can be increased when Levobetaxolol is combined with Pilocarpine.
Levobunolol
The risk or severity of adverse effects can be increased when Levobunolol is combined with Pilocarpine.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Pilocarpine.
Lopinavir
The metabolism of Pilocarpine can be decreased when combined with Lopinavir.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Pilocarpine.
Luliconazole
The serum concentration of Pilocarpine can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Pilocarpine can be increased when combined with Lumacaftor.
Malathion
The risk or severity of adverse effects can be increased when Malathion is combined with Pilocarpine.
Mefloquine
The risk or severity of adverse effects can be increased when Mefloquine is combined with Pilocarpine.
Memantine
The risk or severity of adverse effects can be increased when Memantine is combined with Pilocarpine.
Mepindolol
The risk or severity of adverse effects can be increased when Mepindolol is combined with Pilocarpine.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Pilocarpine.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Pilocarpine.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Pilocarpine.
Metipranolol
The risk or severity of adverse effects can be increased when Metipranolol is combined with Pilocarpine.
Metoclopramide
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Pilocarpine.
Metoprolol
The risk or severity of adverse effects can be increased when Metoprolol is combined with Pilocarpine.
Mifepristone
The serum concentration of Pilocarpine can be increased when it is combined with Mifepristone.
Minaprine
The risk or severity of adverse effects can be increased when Minaprine is combined with Pilocarpine.
Mitotane
The serum concentration of Pilocarpine can be decreased when it is combined with Mitotane.
Nadolol
The risk or severity of adverse effects can be increased when Nadolol is combined with Pilocarpine.
Nebivolol
The risk or severity of adverse effects can be increased when Nebivolol is combined with Pilocarpine.
Nefazodone
The metabolism of Pilocarpine can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Pilocarpine can be decreased when combined with Nelfinavir.
Neostigmine
The risk or severity of adverse effects can be increased when Neostigmine is combined with Pilocarpine.
Netupitant
The serum concentration of Pilocarpine can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Pilocarpine can be increased when combined with Nevirapine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Pilocarpine.
Nicotine
The metabolism of Pilocarpine can be decreased when combined with Nicotine.
Nicotine Polacrilex
The metabolism of Pilocarpine can be decreased when combined with Nicotine.
Nilotinib
The metabolism of Pilocarpine can be decreased when combined with Nilotinib.
O-PHENANTHROLINE
The risk or severity of adverse effects can be increased when 1,10-Phenanthroline is combined with Pilocarpine.
Olaparib
The metabolism of Pilocarpine can be decreased when combined with Olaparib.
Osimertinib
The serum concentration of Pilocarpine can be increased when it is combined with Osimertinib.
Oxprenolol
The risk or severity of adverse effects can be increased when Oxprenolol is combined with Pilocarpine.
Palbociclib
The serum concentration of Pilocarpine can be increased when it is combined with Palbociclib.
Penbutolol
The risk or severity of adverse effects can be increased when Penbutolol is combined with Pilocarpine.
Pentobarbital
The metabolism of Pilocarpine can be increased when combined with Pentobarbital.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Pilocarpine.
Phenobarbital
The metabolism of Pilocarpine can be increased when combined with Phenobarbital.
Phenytoin
The metabolism of Pilocarpine can be increased when combined with Phenytoin.
Physostigmine
The risk or severity of adverse effects can be increased when Physostigmine is combined with Pilocarpine.
Pindolol
The risk or severity of adverse effects can be increased when Pindolol is combined with Pilocarpine.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Pilocarpine.
Posaconazole
The metabolism of Pilocarpine can be decreased when combined with Posaconazole.
Practolol
The risk or severity of adverse effects can be increased when Practolol is combined with Pilocarpine.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Pilocarpine.
Primidone
The metabolism of Pilocarpine can be increased when combined with Primidone.
Propafenone
The risk or severity of adverse effects can be increased when Propafenone is combined with Pilocarpine.
Propranolol
The risk or severity of adverse effects can be increased when Propranolol is combined with Pilocarpine.
Pyridostigmine
The risk or severity of adverse effects can be increased when Pyridostigmine is combined with Pilocarpine.
Pyridostigmine Bromide
The risk or severity of adverse effects can be increased when Pyridostigmine is combined with Pilocarpine.
Ranolazine
The metabolism of Pilocarpine can be decreased when combined with Ranolazine.
Rifabutin
The metabolism of Pilocarpine can be increased when combined with Rifabutin.
Rifampin
The metabolism of Pilocarpine can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Pilocarpine can be increased when combined with Rifapentine.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Pilocarpine.
Rivastigmine
The risk or severity of adverse effects can be increased when Rivastigmine is combined with Pilocarpine.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Pilocarpine.
Rucaparib
The metabolism of Pilocarpine can be decreased when combined with Rucaparib.
Saquinavir
The metabolism of Pilocarpine can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Pilocarpine can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Pilocarpine can be decreased when used in combination with Sarilumab.
Sildenafil
The metabolism of Pilocarpine can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Pilocarpine can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Pilocarpine can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Pilocarpine.
Sotalol
The risk or severity of adverse effects can be increased when Sotalol is combined with Pilocarpine.
ST. JOHN'S WORT EXTRACT
The serum concentration of Pilocarpine can be decreased when it is combined with St. John's Wort.
Sulfisoxazole
The metabolism of Pilocarpine can be decreased when combined with Sulfisoxazole.
Tacrine
The risk or severity of adverse effects can be increased when Tacrine is combined with Pilocarpine.
Talinolol
The risk or severity of adverse effects can be increased when Talinolol is combined with Pilocarpine.
Telaprevir
The metabolism of Pilocarpine can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Pilocarpine can be decreased when combined with Telithromycin.
Terbutaline
The risk or severity of adverse effects can be increased when Terbutaline is combined with Pilocarpine.
Terbutaline Sulfate
The risk or severity of adverse effects can be increased when Terbutaline is combined with Pilocarpine.
Tertatolol
The risk or severity of adverse effects can be increased when Tertatolol is combined with Pilocarpine.
Ticlopidine
The metabolism of Pilocarpine can be decreased when combined with Ticlopidine.
Timolol
The risk or severity of adverse effects can be increased when Timolol is combined with Pilocarpine.
Timolol Anhydrous
The risk or severity of adverse effects can be increased when Timolol is combined with Pilocarpine.
Tocilizumab
The serum concentration of Pilocarpine can be decreased when it is combined with Tocilizumab.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Pilocarpine.
Tubocurarine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Pilocarpine.
Tyrothricin
The risk or severity of adverse effects can be increased when Tyrothricin is combined with Pilocarpine.
Vemurafenib
The serum concentration of Pilocarpine can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Pilocarpine can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Pilocarpine can be decreased when combined with Verapamil.
Voriconazole
The metabolism of Pilocarpine can be decreased when combined with Voriconazole.
Ziprasidone
The metabolism of Pilocarpine can be decreased when combined with Ziprasidone.
